UPSC Darpan

Health & Life SciencesGS2 · GS37 October 2026

Leprosy Transmission Halted in Only 148 Districts Against 300 Projected, Programme Report Shows

Open in the app — quiz, notes, Mistake Vault हिंदी में पढ़ें

The news

New Delhi, October 7. Citing the 2025-26 National Leprosy Elimination Programme report, a Hindu editorial says only 148 districts have achieved ‘interruption of transmission’ — no new local cases — pending field verification, against 300 projected. In 2025-26 workers screened more than 70 crore people in highly endemic areas, detecting 24,367 cases; ASHA workers flagged nearly 40 lakh suspected cases, of which 48,027 were confirmed. Single-dose rifampicin, a preventive dose, reached 91.1% of 16.9 lakh likely contacts. Yet incidence overshot projections by 41%, child incidence by 91.6% and the grade-2 (visible) disability rate by 34%. Chhattisgarh, Jharkhand, Odisha and Maharashtra bear disproportionate shares. Official data (PIB, 2025) put national prevalence at 0.57 per 10,000 in 2024-25 and the child share of new cases at 4.68%.

The chain in one line: Multi-drug therapy shortens time on the register → prevalence falls below 1 per 10,000 by 2005 and WHO declares elimination → surveillance folds into general health services → disability rises again in the early 2010s → screening and the 2023–27 plan target transmission, which still outruns projections

Static syllabus linkage

  1. “Elimination as a public health problem” means low prevalence, not zero cases. WHO sets it at registered prevalence below 1 per 10,000 people. Prevalence counts patients on treatment, so shorter therapy lowers it even while infection spreads; new, child and disability cases are truer signals. Leprosy is caused by Mycobacterium leprae.
  2. The 2023–27 plan targets transmission, and the law has dropped an old stigma. The National Strategic Plan and Roadmap for Leprosy 2023–27 aims at interrupting transmission by 2030, per a PIB document; the Health Ministry has been reported as targeting “zero transmission” by 2027. Leprosy became notifiable by all health sectors in 2025. The Personal Laws (Amendment) Act, 2019 removed it as a ground for divorce.

Why UPSC loves this

  1. Neglected diseases test GS2’s health line. The syllabus asks about “Social Sector/Services relating to Health”; leprosy adds stigma, child cases and regional inequality, and Prelims favours prevalence versus incidence.

Prelims nuggets

  • WHO’s ‘elimination as a public health problem’ for leprosy means prevalence below 1 per 10,000; India achieved it nationally in 2005.
  • Single-dose rifampicin is given to contacts of leprosy patients as post-exposure prophylaxis.
  • The Personal Laws (Amendment) Act, 2019 removed leprosy as a ground for divorce under five personal laws.
  • WHO’s Global Leprosy Strategy 2021–2030 is titled “Towards zero leprosy”.

Analysis

  1. The overshoot is partly better detection and partly a bill from the past. Screening 70 crore people is bound to raise recorded incidence, so part of the 41% overshoot is hidden cases surfacing. But grade-2 disability, the mark of late diagnosis, also overshot, so many patients still reach care after nerve damage. Detection is improving faster than transmission is falling.
  2. Lens — Short-term relief and long-term reform: declaring victory early is cheap now and costly later. The 2005 declaration freed money and attention, and the programme lost its own surveillance; the bill came as rising disability. Today, easing detection or revising targets would flatter the numbers, and two dates — 2027 as reported, 2030 in a PIB document — make a quiet goalpost shift easy. A thoughtful officer keeps the 300-district projection and gets ‘interruption’ verified independently.
  3. Leprosy is a disease of where you live, so equity means spending unevenly. A national 0.57 per 10,000 hides endemic pockets in four States, where poverty, crowding and stigma delay care and doctors mistake leprosy for a skin condition. Trained screeners in endemic blocks, enforced private-sector notification and anti-stigma work will do more than another national campaign.

Possible Mains question

“Leprosy was eliminated in 2005 but never ended.” To what extent has India’s strategy shifted from prevalence to transmission? (15 marks, 250 words)

Model approach

  1. Directive — To what extent. Judge how far the shift has gone, with evidence both ways.
  2. Introduction — a threshold mistaken for an end. The WHO definition and India’s 2005 milestone.
  3. Body — the design has shifted. NSP 2023–27, prophylaxis to 91.1% of contacts, ASHA referrals, universal notification.
  4. Body — results lag the design. 148 of 300 districts; incidence and disability above projections. Value addition: WHO strategy 2021–2030. Draw falling prevalence against child cases.
  5. Conclusion — measure transmission, not prevalence. Hold targets, verify independently, focus on four States.

Administrator's brainstorm

As Chief Medical Officer, you find a child case in a block reported transmission-free. What do you do?

A child case signals recent transmission, so I would report it and treat the block’s status as provisional. I would examine household and neighbourhood contacts, give eligible contacts rifampicin, check whether verification relied on desk data, and work with the school so the child is not stigmatised.